Authors: Sharon Salt, Editor
An international team of researchers have successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.
In the study, published in mBio®, the team demonstrate that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer.
Restricted Content / Members Only
